Binbin Xue
Impact in
- Immunology top 5%
- interferon and immune responses
- Hepatology top 10%
- Hepatitis C virus research
Papers in
- Immunology 11
- interferon and immune responses 11
-
- Hepatitis C virus research 6
- Co-authors
- Haizhen Zhu (25 shared papers)Darong Yang (10 shared papers)Huiyi Li (13 shared papers)Mengmeng Guo (6 shared papers)Rilin Deng (13 shared papers)Guangdi Li (4 shared papers)Renyun Tian (13 shared papers)Nianli Liu (7 shared papers)
- Journals
- Journal of Virology (10 papers)PLoS ONE (3 papers)Antiviral Research (2 papers)Journal of the American Chemical Society (2 papers)Microbiology Spectrum (2 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Binbin Xue
27 papers receiving 943 citations
Peers
Comparison fields: 5 of 51
- Immunology 223
- Hepatology 56
- Molecular Biology 247
- Cancer Research 29
- Epidemiology 67
Countries citing papers authored by Binbin Xue
This map shows the geographic impact of Binbin Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Binbin Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Binbin Xue more than expected).
Fields of papers citing papers by Binbin Xue
This network shows the impact of papers produced by Binbin Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Binbin Xue. The network helps show where Binbin Xue may publish in the future.
Co-authors
The 25 scholars most cited alongside Binbin Xue, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 135 | |
| 2 | 2019 | 98 | |
| 3 | 2014 | 92 | |
| 4 | 2017 | 77 | |
| 5 | 2018 | 67 | |
| 6 | 2021 | 63 | |
| 7 | 2020 | 59 | |
| 8 | 2016 | 53 | |
| 9 | 2013 | 45 | |
| 10 | 2020 | 44 | |
| 11 | 2015 | 41 | |
| 12 | 2014 | 35 | |
| 13 | 2014 | 30 | |
| 14 | 2014 | 21 | |
| 15 | 2022 | 19 | |
| 16 | 2022 | 16 | |
| 17 | 2013 | 15 | |
| 18 | 2015 | 12 | |
| 19 | 2022 | 10 | |
| 20 | 2024 | 7 |
About Binbin Xue
Binbin Xue is a scholar working on Immunology, Hepatology, Epidemiology, Molecular Biology and Nuclear Energy and Engineering, having authored 27 papers that have together received 967 indexed citations. Recurring topics across this work include interferon and immune responses (11 papers), Hepatitis C virus research (6 papers), Hepatitis B Virus Studies (3 papers), DNA and Nucleic Acid Chemistry (2 papers), Inflammasome and immune disorders (1 paper) and Cell death mechanisms and regulation (1 paper). The work is most often cited by research in Immunology (223 citations), Hepatology (56 citations), Molecular Biology (247 citations), Cancer Research (29 citations) and Epidemiology (67 citations). Binbin Xue has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Haizhen Zhu, Darong Yang, Huiyi Li, Mengmeng Guo, Rilin Deng, Guangdi Li, Renyun Tian, Nianli Liu, Xiaohong Wang and Jingjing Wang. Their work appears in journals such as Journal of Virology, PLoS ONE, Antiviral Research, Journal of the American Chemical Society and Microbiology Spectrum.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.